New breast cancer drug candidate tested in healthy women first
NCT ID NCT06995482
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tests a new drug called KSHN001034 in 40 healthy postmenopausal women to see if it is safe and how the body processes it. The drug is similar to an existing breast cancer treatment, Faslodex. Participants receive either the new drug or the existing one at different doses, and researchers monitor side effects and drug levels in the blood.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY POSTMENOPAUSAL WOMEN are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Floridian Clinical Research LLC
RECRUITINGMiami Lakes, Florida, 33016, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Synergen Bio Pvt. Ltd.
RECRUITINGPune, Maharashtra, 411003, India
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.